Atea Pharmaceuticals | 10-Q:2024財年二季報
Atea Pharmaceuticals | 8-K:Atea Pharmaceuticals公佈2024年第二季度財務業績並提供業務最新情況
Atea Pharmaceuticals | 4:持股變動聲明-董事 Duncan Barbara Gayle
Atea Pharmaceuticals | 4:持股變動聲明-董事 BERGER FRANKLIN M
Atea Pharmaceuticals | 4:持股變動聲明-董事 Adams Jerome M.
Atea Pharmaceuticals | 4:持股變動聲明-董事 Polsky Bruce
Atea Pharmaceuticals | 4:持股變動聲明-董事 Lucidi Bruno
Atea Pharmaceuticals | 4:持股變動聲明-董事 Murphy Polly A.
Atea Pharmaceuticals | 8-K:重大事件
Atea Pharmaceuticals | 144:擬議出售證券
Atea Pharmaceuticals | 4:持股變動聲明-董事 Adams Jerome M.
Atea Pharmaceuticals | 4:持股變動聲明-董事 Polsky Bruce
Atea Pharmaceuticals | 4:持股變動聲明-董事 BERGER FRANKLIN M
Atea Pharmaceuticals | 4:持股變動聲明-董事 Lucidi Bruno
Atea Pharmaceuticals | 4:持股變動聲明-董事 Murphy Polly A.
Atea Pharmaceuticals | 4:持股變動聲明-董事 Duncan Barbara Gayle
Atea Pharmaceuticals | 4:持股變動聲明-高管 Sommadossi Jean-Pierre
Atea Pharmaceuticals | 144:擬議出售證券
Atea Pharmaceuticals | DEFA14A:其他
Atea Pharmaceuticals | 10-Q:2024財年一季報
暫無數據